G01N 33/5005
Involving human or animal cells
Official title: {involving human or animal cells (immunoassay G01N33/56966; immunoassays of protozoa G01N33/56905; protozoa in screening assays C12Q1/025)}
G01N33/5005 (Involving human or animal cells) appears on 12,795 US grants and 23,974 published applications in this corpus.
Search patents in G01N- Granted patents
- 12,795
- Published applications
- 23,974
- Assignees
- 6,618
- Inventors
- 40,752
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 2 | 0 |
| 1978 | 5 | 0 |
| 1979 | 6 | 0 |
| 1980 | 6 | 0 |
| 1981 | 10 | 0 |
| 1982 | 14 | 0 |
| 1983 | 7 | 0 |
| 1984 | 12 | 0 |
| 1985 | 14 | 0 |
| 1986 | 19 | 0 |
| 1987 | 13 | 0 |
| 1988 | 34 | 0 |
| 1989 | 34 | 0 |
| 1990 | 27 | 0 |
| 1991 | 31 | 0 |
| 1992 | 34 | 0 |
| 1993 | 58 | 0 |
| 1994 | 54 | 0 |
| 1995 | 56 | 0 |
| 1996 | 90 | 0 |
| 1997 | 131 | 0 |
| 1998 | 209 | 0 |
| 1999 | 226 | 0 |
| 2000 | 168 | 0 |
| 2001 | 221 | 70 |
| 2002 | 209 | 502 |
| 2003 | 217 | 1680 |
| 2004 | 185 | 736 |
| 2005 | 174 | 785 |
| 2006 | 308 | 791 |
| 2007 | 329 | 846 |
| 2008 | 367 | 705 |
| 2009 | 301 | 869 |
| 2010 | 401 | 877 |
| 2011 | 416 | 858 |
| 2012 | 440 | 861 |
| 2013 | 456 | 926 |
| 2014 | 541 | 1154 |
| 2015 | 580 | 1174 |
| 2016 | 624 | 1114 |
| 2017 | 654 | 1109 |
| 2018 | 703 | 1118 |
| 2019 | 664 | 1138 |
| 2020 | 683 | 1133 |
| 2021 | 563 | 1158 |
| 2022 | 564 | 1120 |
| 2023 | 490 | 919 |
| 2024 | 579 | 967 |
| 2025 | 503 | 799 |
| 2026 | 361 | 565 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- System and method for determining an immune activation state6 Oct 2026US 12,752,274 B2CytoVale Inc.
- ß-amyloid cyclic ribonucleic acid, polypeptide, and application thereof6 Oct 2026US 12,753,215 B2
- Bioactive agents and methods related thereto6 Oct 2026US 12,753,216 B2Aroa Biosurgery Limited
- Liquid crystal scaffolds and use thereof for organoid, spheroid, and 3D cellaggregate manufacturing6 Oct 2026US 12,753,393 B2The Regents of the University of California
- Single-cell-based electrochemical sensor based on functionalized nano-probe and application thereof6 Oct 2026US 12,754,158 B2Jiangnan University
- Transgenic model of human cardiomyopathy8 Oct 2026US 2026/0305586 A1Stichting Genetische Hartspierziekte PLN
- Trem2 agonists for the stimulation of microglia and methods of identification8 Oct 2026US 2026/0306439 A1The Translational Genomics Research Institute
- Composition for inducing immunotolerance8 Oct 2026US 2026/0306540 A1
- Targeted Immune Cell Therapy Utilizing TRAIL and TNF Mediated Apoptosis8 Oct 2026US 2026/0306542 A1Northeastern University
- Molecular-genetic strategy for the reactivation of juvenile plasticity in targeted adult neural circuits8 Oct 2026US 2026/0306662 A1The Regents of the University of California
Most cited
By later US patents
- Fluorescent silica-based nanoparticles1,448US 8,298,677 B2Cornell Research Foundation, Inc. · 2012
- High throughput screening assay systems in microscale fluidic devices877US 5,942,443 ACaliper Technologies Corp. · 1999
- Patient classification703US 6,763,307 B2Bioseek, Inc. · 2004
- High throughput screening assay systems in microscale fluidic devices692US 6,046,056 ACaliper Technologies Corp. · 2000
- Regulation of endogenous gene expression in cells using zinc finger proteins648US 6,534,261 B1Sangamo BioSciences, Inc. · 2003